Market revenue in 2023 | USD 344.4 million |
Market revenue in 2030 | USD 439.1 million |
Growth rate | 3.5% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Kits & Reagents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Lateral Flow Readers |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Roche, Bio-Rad Laboratories Inc, BioMerieux SA, QuidelOrtho Corp, Hologic Inc, PerkinElmer, Merck KGaA, BD, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lateral flow assays market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 68.87% in 2023. Horizon Databook has segmented the Brazil lateral flow assays market based on kits & reagents, lateral flow readers covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in prevalence of infectious diseases is expected to propel market growth in Brazil during the forecast period. The Zika virus was spread by mosquitos, and its outbreak affected about 34 countries in 2016. Brazilian authorities reported 1.5 million cases of Zika virus infections in 2016.
It was the hardest-hit country during the outbreak. Most Zika-associated malformations in newborns were reported in Brazil. Furthermore, the Brazilian Ministry of Health recorded 6,483 cases from January 2021 to January 2022.
Similarly, the country suffers from a high incidence of diabetes. According to the International Diabetes Foundation, over 15 million people in the country are living with diabetes in 2021, while diabetes-related health expenditure has reached USD 42.9 billion in the same year.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil lateral flow assays market , including forecasts for subscribers. This country databook contains high-level insights into Brazil lateral flow assays market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account